Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2012
10/31/2012CN102125570B Use of chikusetsusaponin v and/or total saponins of panax japonicas in preparation of antithrombotic agents
10/30/2012US8299029 Stabilised solid compositions of factor VII polypeptides
10/30/2012CA2513280C Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition plasma kallikrein
10/30/2012CA2454341C Plasma protein matrices and methods for their preparation
10/26/2012WO2012144613A1 Method for producing complex crystal and method for screening complex crystal
10/26/2012WO2012143143A1 Heterocyclic compounds as kinase inhibitors
10/26/2012WO2012142696A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012WO2012118277A3 Composition for promoting hematogenesis, containing quercetin 3-o-β-(2''-galloyl)rhamnoside as active ingredient
10/26/2012WO2012115940A3 A method of inducing hematopoietic reconstruction
10/26/2012WO2012112007A3 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock
10/26/2012CA2833614A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/25/2012US20120270902 N-substituted benzene sulfonamides
10/25/2012US20120270899 Compositions and Methods for Treating Cardiovascular Diseases
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270849 Combinations of niacin, omega-3 and plant sterols/stanols for prevention cholesterol treatment
10/25/2012US20120270846 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270834 Depolymerized glycosaminoglycan from thelenota ananas and preperation method thereof
10/25/2012US20120270810 Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270789 Treatment of coagulopathy with hyperfibrinolysis
10/25/2012US20120270788 Method of Administering Porcine B-Domainless fVIII
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270780 Method and composition for modulating erythropoiesis
10/25/2012US20120270266 Nucleic ac1d and amino ac1d sequences encoding high-level expressor factor viii polypeptides and methods of use
10/25/2012US20120269907 Dialysis Machine Control
10/25/2012US20120269898 Compositions and methods of treating pulmonary hypertension
10/25/2012US20120269817 Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor
10/25/2012US20120269810 Methods and compositions for panic disorders
10/25/2012US20120269788 Antidotes for factor xa inhibitors and methods of using the same
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269786 Systemic, allogenic stem cell therapies for treatment of diseases in felines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012DE102011018372A1 Producing preparation made of medical leech, comprises washing leech that is in regime of active starvation, freezing and crushing mass, and producing medicinal forms from mass
10/25/2012DE102011007891A1 New ring-fused 4-aminopyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease and renal insufficiency
10/25/2012DE102011007890A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
10/24/2012EP2514757A2 Glycopegylated granulocyte colony stimulating factor
10/24/2012EP2514432A1 Sea cucumber compound preparation and preparation method thereof
10/24/2012EP2514431A1 A sea cucumber compound product, preparation method and preparation forms thereof
10/24/2012EP2513299A1 Decellularized adipose tissue
10/24/2012EP2513094A2 Salts and crystalline forms of a factor xa inhibitor
10/24/2012EP2513058A1 Methods of synthesizing factor xa inhibitors
10/24/2012EP2512466A1 Prodrugs of inhibitors of plasma kallikrein
10/24/2012CN102753548A Fused heteroaromatic pyrrolidinones
10/24/2012CN102753147A Liquid formulations for long-acting erythropoietin conjugate
10/24/2012CN102746697A Technology for extracting yellow pigment from red dates
10/24/2012CN102746363A High purity aescine B bulk drug, its preparation method and medical application
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
10/24/2012CN102746287A Oxazolidinone compound and preparation method thereof
10/24/2012CN102746181A 4-methoxy-N,N'-disubstituted phenyl-1,3-benzene diamide compounds and application thereof
10/24/2012CN102746159A 4-methoxy-1,3-phthalic diester derivative, and preparation and application thereof
10/24/2012CN102746153A Chlorogenic acid compound and pharmaceutical composition thereof
10/24/2012CN102743730A Traditional Chinese medicine wine for treating arthritis and preparation method
10/24/2012CN102743729A Oral hemostasis soup for treating gynaecologic haemorrhagia and preparation method thereof
10/24/2012CN102743710A Anti-cancer and hemostatic Chinese patent drug
10/24/2012CN102743694A Embolism-prevention shampoo
10/24/2012CN102743598A var. Denneanum extract and formula particles thereof
10/24/2012CN102743579A Qi tonifying and blood replenishing Chinese medicinal pills and preparation process thereof
10/24/2012CN102743499A Chinese medicinal herb drug for treating soft tissue internal injury blood stasis and cerebral hemorrhage
10/24/2012CN102743489A Chinese medicinal prescription for treating blood-deficiency type irregular menstruation
10/24/2012CN102743482A Traditional Chinese medicine for preventing postpartum pulmonary embolism
10/24/2012CN102743470A Spleen strengthening and qi tonifying tablets
10/24/2012CN102743399A Application of mulberroside to preparation of diuretic medicine
10/24/2012CN102743386A Tetramethylpyrazine and borneol dropping pill for treating ardiovascular and cerebrovascular diseases and preparation method for dropping pill
10/24/2012CN102743385A Modulators of atp-binding cassette-transporters
10/24/2012CN102743345A Small-size tranexamic acid freeze-dried powder injection, preparation method and production device thereof
10/24/2012CN102743331A Disinfection preparation containing levorotatory folinic acid sodium
10/24/2012CN102742940A Briefs for adjuvant therapy of urine retention after operation
10/24/2012CN102058620B Fistula affused liquid medicine for anal fistula
10/23/2012US8293234 Antibodies which bind and inhibit blood factor VIII
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/23/2012CA2418411C Inhibitory, monoclonal antibody against blood clotting factor vii-activating protease
10/23/2012CA2334679C Pyrazinone protease inhibitors
10/18/2012WO2012142317A1 Fast-clotting wound dressings
10/18/2012WO2012141536A2 Composition for regenerating connective tissue, and method for regenerating connective tissue
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139422A1 Novel anti-platelet compound addition salt
10/18/2012WO2012103512A3 Expanded utility of red cell-derived microparticles (rmp) for treatment of bleeding
10/18/2012WO2012102555A3 Fucoidan for thrombolysis, derived from seaweed
10/18/2012US20120266262 Methods and compositions relating to zpa polypeptides
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264815 Reversible platelet inhibition
10/18/2012US20120264798 Prodrugs of inhibitors of plasma kallikrein
10/18/2012US20120264794 Method for Preparing Largazole Analogs and Uses Thereof
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264773 Organic compounds
10/18/2012US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264725 Substituted porphyrins
10/18/2012US20120264721 Analogues of cilostazol
10/18/2012US20120264718 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
10/18/2012US20120264692 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/18/2012US20120264687 Modified erythropoietin to which water-soluble long-chain molecule is added
10/18/2012US20120264686 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 671